Active, Not Recruiting
Durvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer
NCT02962063
- Conditions
- Adenocarcinoma Of Esophagus, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
- Locations
-
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack Commack, New York, United States
- Memorial Sloan Kettering Westchester Harrison, New York, United States